http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1080192-A2

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_7a2bfd291c1e3d2cf70aa37bbf294727
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N2310-315
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N15-113
classificationIPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-00
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-70
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-113
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07H21-00
filingDate 1999-05-20-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5b67682cac7c5545d6d398ca63a289ee
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_6e625b05f8be69b899bbffa8c2d24a2f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a5e7c6509814aa04169ec200a81c0fc0
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7de3e25d62d27f3bb4a03c2e5fdd2a52
publicationDate 2001-03-07-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber EP-1080192-A2
titleOfInvention Antisense oligonucleotides for treating proliferating cells
abstract The invention relates to oligoribo- and oligodesoxyribonucleotides which are suitable for treating pathological conditions that are accompanied by increased cell proliferation. Said oligoribo- and oligodesoxyribonucleotides are characterised in that they are able to hybridise with the mRNA which codes the protein Ki-67, this protein being associated with the cell cycle.
priorityDate 1998-05-22-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCO97399
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ59149
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129721016
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID11801
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP81071
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3641960
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4939
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP19799
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129765906
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128896283
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129062291
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP24664
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID9215
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID137199
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID444020
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226409109
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129888650
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID10986553
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID135812317
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP35034
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID4757
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129710170
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128774280
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP35051
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP51588
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP83348
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP35048
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP00761
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP70059
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP00764
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP35049
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226397450
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP23916
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID13818
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP00775
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP35050

Total number of triples: 55.